Advertisement

Topics

Ophthotech Corporation Company Profile

10:09 EDT 25th June 2018 | BioPortfolio

Ophthotech Corporation is a privately held biopharmaceutical company based in Princeton, NJ focused on developing and commercializing therapies for dry and wet AMD. Ophthotech is developing a pipeline of compounds with strong scientific foundations for the treatment of AMD, with the goal of bringing them to market in an accelerated manner. Ophthotech’s venture investors include SV Life Sciences Advisers, Novo Ventures, HBM Partners and Clarus Ventures. For more information, please visit www.ophthotech.com.


News Articles [112 Associated News Articles listed on BioPortfolio]

Ophthotech’s Share Price Increases on New Collaboration

On Thursday, Ophthotech announced it has entered into an exclusive global license agreement with the University of Florida Research Foundation and the University of Pennsylvania. The post Ophthotech&#...

Ophthotech’s Share Price Increases With New Collaboration

On Thursday, Ophthotech announced it has entered into an exclusive global license agreement with the University of Florida Research Foundation and the University of Pennsylvania. The post Ophthotech&#...

Ophthotech Corporation to Present at the 36th Annual J.P. Morgan Healthcare Conference

- Webcast Available Through Ophthotech Website - Ophthotech Corporation (NASDAQ: OPHT) announced today that Glenn P. Sblendorio, Chief Executive Officer and President, will pr...

Ophthotech to Present at the Cowen and Company 38th Annual Health Care Conference

Ophthotech Corporation (Nasdaq: OPHT) announced today that Kourous A. Rezaei, M.D., Chief Medical Officer, will present an overview of the Company at the Cowen and Company 38th An...

Ophthotech completes enrolment in Phase IIa trial of Zimura

Ophthotech has completed patient enrolment in its Phase IIa clinical trial of Zimura (avacincaptad pegol) in combination with Lucentis (ranibizumab)...Read More... The post Ophthotech completes enrolm...

Ophthotech Corporation to Report Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on Tuesday, February 27, 2018

Ophthotech Corporation (Nasdaq:OPHT) today announced that it will report its fourth quarter and full year 2017 financial and operating results on Tuesday, February 27, 2018. Follo...

Ophthotech Corporation to Report First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018

Ophthotech Corporation (Nasdaq:OPHT) today announced that it will report its first quarter 2018 financial and operating results on Wednesday, May 9, 2018. Following the announceme...

Active-Investors: Blog Exposure - Ophthotech Initiates Research Collaborations to Discover Treatments for Orphan and Age-Related Retinal Diseases

Stock Monitor: Spark Therapeutics Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 01, 2018 / Active-Investors.com has just released a free research report on Ophthotech Corp. (NASDAQ: OPHT)...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [176 Associated Companies listed on BioPortfolio]

Ophthotech Corp.

Ophthotech Corp. is a privately held biopharmaceutical company based in Princeton, NJ and New York, NY focused on developing and commercializing therapies for back-of-the-eye diseases. Ophthotech plan...

Ophthotech Corporation

Ophthotech Corporation is a privately held biopharmaceutical company based in Princeton, NJ focused on developing and commercializing therapies for dry and wet AMD. Ophthotech is ...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

NEC Corporation of America

NEC Corporation of America (NEC) is a leading technology integrator providing solutions that improve the way people work and communicate. NEC delivers integrated Solutions for Soc...

More Information about "Ophthotech Corporation" on BioPortfolio

We have published hundreds of Ophthotech Corporation news stories on BioPortfolio along with dozens of Ophthotech Corporation Clinical Trials and PubMed Articles about Ophthotech Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ophthotech Corporation Companies in our database. You can also find out about relevant Ophthotech Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...


Corporate Database Quicklinks



Searches Linking to this Company Record